84
55
Growth Score 84 in past quarter
-3 pts
Heat Score 55 in past quarter
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1111537
EpiDestiny develops non-cytotoxic epigenetic drugs that work with nature.
- Santhosh Vadivelu: FounderPast Role: Neuro Therapia, Acting CEO
About the Company
EpiDestiny develops non-cytotoxic epigenetic drugs that work with nature, not against it, to kindly and meaningfully treat sickle cell, thalassemia, and cancer